ARTICLE | Clinical News
Zostavax regulatory update
May 29, 2006 7:00 AM UTC
FDA granted marketing approval to MRK for Zostavax zoster vaccine to prevent herpes zoster (shingles) in adults 60 years or older. The approved label was more narrow than MRK’s proposed label of preve...